• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Down 0.18%

    More On GLAXF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    GlaxoSmithKline plc (GLAXF)

    -Other OTC
    21.00 Down 0.27(1.27%) May 5, 12:00PM EDT
    |Pre-Market : NaN
    Prev Close:21.27
    Open:21.00
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:1.13884
    Next Earnings Date:N/A
    Day's Range:21.00 - 21.00
    52wk Range:18.45 - 23.35
    Volume:2,142
    Avg Vol (3m):20,361
    Market Cap:101.64B
    P/E (ttm):8.38
    EPS (ttm):2.51
    Div & Yield:1.11 (5.14%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):0.23
    P/S (ttm):2.96
    Ex-Dividend Date:12-May-16

    Analysts

    Annual EPS Est (Dec-16) :88.55
    Quarterly EPS Est (Jun-16) :20.55
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):1.77

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback